FEED (ENvue Medical) Cyclically Adjusted PB Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FEED ENvue Medical Inc FEED
37 GF Score
Price $0.41
GF Value $5.01
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is ENvue Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ENvue Medical  (NAS:FEED) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


ENvue Medical Cyclically Adjusted PB Ratio Related Terms


ENvue Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for ENvue Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENvue Medical Cyclically Adjusted PB Ratio Chart

ENvue Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ENvue Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FEED vs BTCY, VYCO, ADMT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, ENvue Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ENvue Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ENvue Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ENvue Medical's Cyclically Adjusted PB Ratio falls into.


FEED
37GF Score
ENvue Medical Inc FEED
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENvue Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

ENvue Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, ENvue Medical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.996/333.9520*333.9520
=4.996

Current CPI (Jun. 2026) = 333.9520.

ENvue Medical Quarterly Data

Book Value per Share CPI Adj_Book
201609 -1,605.000 241.428 -2,220.094
201612 -2,501.000 241.432 -3,459.417
201703 -2,805.000 243.801 -3,842.213
201706 -3,053.000 244.955 -4,162.215
201709 -4,291.000 246.819 -5,805.825
201712 1,816.000 246.524 2,460.032
201803 1,476.000 249.554 1,975.176
201806 1,109.000 251.989 1,469.718
201809 692.000 252.439 915.448
201812 230.500 251.233 306.393
201903 -235.500 254.202 -309.383
201906 965.500 256.143 1,258.792
201909 1,113.000 256.759 1,447.617
201912 672.000 256.974 873.301
202003 247.000 258.115 319.571
202006 -394.000 257.797 -510.390
202009 543.833 260.280 697.764
202012 239.200 260.474 306.677
202103 395.000 264.877 498.009
202106 378.364 271.696 465.062
202109 725.750 274.310 883.547
202112 485.615 278.802 581.675
202203 404.692 287.504 470.072
202206 318.000 296.311 358.396
202209 242.615 296.808 272.977
202212 215.533 296.797 242.515
202303 146.867 301.836 162.494
202306 77.667 305.109 85.009
202309 275.882 307.789 299.333
202312 209.895 306.746 228.511
202403 140.160 312.332 149.862
202406 113.640 314.175 120.794
202409 74.880 315.301 79.309
202412 16.500 315.605 17.459
202503 469.408 319.799 490.182
202506 51.432 322.561 53.248
202509 42.002 324.800 43.186
202512 30.452 324.054 31.382
202603 8.650 330.213 8.748
202606 4.996 333.952 4.996

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is ENvue Medical (FEED) Overvalued in 2026?

Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued. The current stock price of $0.41 is trading 91.9% below its estimated GF Value™ of $5.01. GuruFocus considers ENvue Medical to be Possible Value Trap.

Key valuation signals for FEED:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $5.01 vs. price of $0.41 (91.9% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the FEED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ENvue Medical Business Description

Address 969 Pruitt Avenue, Tyler, TX, USA, 77569
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
37GF Score

Get the complete analysis for FEED

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.41
Price
$5.01
GF Value